Polyneuropathy is a diverse group of disorders related to the peripheral nerves. Usually, this is a systemic process with the involvement of multiple nerves resulting from various internal and external causes (such as inflammation, metabolic, immunopathogenic mechanisms, toxic factors, nutritional and vitamin deficiency, degenerative causes, and so on).

The usual symptoms of polyneuropathy include tingling, burning, pain, reduced sensitivity, uncertain walking, muscle weakness, aches and spasms, and many other symptoms.

The most commonly occurring types of polyneuropathy:

• acute and chronic inflammatory demyelinating polyneuropathy (in this case, the specific immunoglobulin and cortical treatment is distributed),
• polyneuropathy in rheumatoid arthritis,
• diabetic neuropathy (in diabetic patients with vascular disorders),
• alcoholic polyneuropathy (caused particularly by a lack of thiamine and vitamin B12 plus toxic influences),
• polyneuropathy in Lyme disease with painful symptoms in the muscoskeletal system,
• toxic polyneuropathy – e.g. after intoxication by benzene, carbon disulphide, lead, mercury, etc.,
• polyneuropathy after neurotoxic drugs (Nidrazid, some cytostatics, etc.), etc.

In all these cases, symptomatic and supporting therapy treating partial symptoms of the disease is applied, especially: analgesic, anti-inflammatory, vasodilatory, anticlotting, etc.

Read the results of the following clinical studies that demonstrate the success rate of low-frequency pulsed magnetic therapy in treatment of this condition.